Data analytics hold potential to extend healthy human lifespan, say experts
Expert panelists said that, as aging research evolved, the integration of large-scale data analytics with clinical trials was reshaping the understanding of healthy aging.
The session at the Global Healthspan Summit, of which Arab News is a media partner, highlighted key national-level initiatives such as France's Instituts Hospitalo-Universitaires HealthAge and the UK's Our Future Health.
Dr. Bruno Vellas, founder of the IHU HealthAge in Toulouse, set the stage by underlining the necessity of improving medical practices to align with innovative research.
'There is a need to change medical practice based on the evidence gathered,' he said, stressing the importance of integrating lifestyle factors into healthcare models.
Vellas noted that while data analytics offered immense benefits, they represented only part of the solution.
'To achieve optimal outcomes, findings must be translated into clinical practice,' he said.
The panel featured diverse voices including Dr. Raghib Ali, CEO and chief investigator of Our Future Health, who echoed the need for inclusive research practices.
'The focus is to produce evidence that is relevant to diverse populations, particularly those of South Asian and African descent,' he said, highlighting the urgency of addressing health disparities. 'It is essential to ensure that the innovations developed are accessible to all, not just those with the highest incomes.'
Dr. Nikole Kimes, co-founder and CEO of Siolta Therapeutics, provided insights into how advanced analytics allowed researchers to move beyond traditional reductionist approaches in medicine.
'What advanced analytics enables is a shift from merely treating symptoms to understanding the complex interactions within biological systems,' she explained.
Emphasizing the importance of longitudinal studies, Kimes said: 'These studies allow for an examination of health outcomes before disease symptoms manifest, providing a crucial advantage in preventative care.'
She also pointed to an emerging understanding of microbiome and nutrition in shaping long-term health outcomes. 'By exploring these early factors, it is possible to potentially alleviate chronic diseases before they take root,' she said.
Dr. Richard I. Morimoto, a leading researcher from Northwestern University, elaborated on the cellular mechanisms underlying stress responses.
'Stress, often viewed negatively, can actually be protective at the molecular level,' he said, emphasizing the significance of understanding interpersonal variability in stress responses and advocating for personalized healthcare strategies.
'By harnessing large data analyses, it is possible to uncover how different individuals respond to stress and how to protect against disease,' he said.
'The integration of longitudinal studies and big data opens tremendous opportunities for detecting and mitigating health risks.'
He added that understanding cellular mechanisms in diverse populations was essential for tailoring interventions effectively.
However, as the panel discussed the potential of these innovations, they also acknowledged the challenges in translating research into practice.
Vellas pointed out the need for robust frameworks that could effectively incorporate findings into clinical settings. 'There is a need to work diligently to avoid negative trial outcomes and ensure that research translates into tangible benefits for populations,' he warned.
The sentiment was echoed by Ali, who stressed the importance of identifying barriers to effective implementation. 'It is critical to map out the stages in the journey from lab research to everyday life,' he said, highlighting the role of evidence-based practices in shaping public health interventions.
The discussions also touched on the ethical dimensions of research into extending the healthy human lifespan.
Kimes pointed out the responsibility researchers have in ensuring findings did not worsen health inequality.
'As new interventions are developed, it is vital to remain vigilant about their accessibility and affordability,' she said.
Her view aligned with Ali's commitment to producing research with a global impact. 'It is essential that findings benefit not only the UK but also communities worldwide,' he said.
In closing, the panelists underscored the critical importance of collaboration across disciplines and borders.
As the field of aging research continues to evolve, the insights shared highlighted the transformative potential of advanced data analytics and longitudinal studies. The prioritization of preventative care and research inclusiveness means experts are paving the way for a paradigm shift in the way healthy aging is approached.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Makkah Newspaper
7 days ago
- Makkah Newspaper
Saudi FDA Leading a Journey of Continuous Excellence and Development
Dear reader, according to recent reports and statistics from the Saudi Food and Drug Authority (SFDA), significant and remarkable developments have been achieved over the past few years across all regulated sectors. These developments have solidified the SFDA's standing as a leading regulatory body, not only in the region but also globally. This continuous advancement is part of broader efforts to improve and regulate pharmaceuticals, medical devices, and food products, sectors that are critically important to public health. SFDA is notably one of only three national regulatory bodies worldwide, alongside those of Singapore and South Korea, to have attained maturity level four (ML4) in the regulation of medicines and vaccines, according to the World Health Organization (WHO). Achieving this highest level of regulatory competency underscores the exceptional capabilities and efficiency of the SFDA. Furthermore, in 2023, the SFDA became the first Arab member of the Pharmaceutical Inspection Co-operation Scheme (PIC/S), an achievement that highlightsinternational trust in Saudi Arabia's pharmaceutical oversight capabilities. Additionally, the SFDA collaborates closely with prominent global organizations such as the International Medical Device Regulators Forum (IMDRF), the International Council for Harmonisation (ICH) of pharmaceuticals, and Codex Alimentarius, which ensures global food safety standards. These partnerships significantly contribute to harmonizing local and international regulatory systems and standards, enhancing the quality of healthcare and food products both within Saudi Arabia and internationally. The SFDA's regulatory role has notably expanded beyond its traditional functions of approving pharmaceuticals and medical devices. At the recent Global HealthSpan Summit held in Riyadh, Dr. Hisham Bin Saad Al-Jadhey, CEO of the Saudi Food and Drug Authority (SFDA), emphasized that the role of regulatory authorities has become increasingly comprehensive and influential. He explained that SFDA's responsibilities now extend beyond ensuring safety and efficacy to actively supporting innovation, adopting advanced health technologies, and regulating health practices that impact all aspects of the healthcare system. A key component of these broader responsibilities is the growing emphasis on the role of nutrition in public health. Recognizing Saudi Arabia's high incidence of chronic diseases such as diabetes and obesity, the SFDA has launched several practical initiatives aimed at reducing these health challenges. These include implementing clear labeling of calorie content, restricting salt content, and minimizing sugar and trans fats in food products. These initiatives are not limited to food alone but extend to incorporating modern health technologies into daily societal practices, significantly contributing to public health improvements and reducing hospital admissions related to chronic diseases. Moreover, the SFDA plays a crucial role in stimulating investment and growth within the regulated sectors by creating a safe and efficient regulatory environment that encourages innovation and product development. Balancing safety, efficiency, and innovation not only fosters growth in local healthcare industries but also enhances Saudi Arabia's global reputation as a leading investment and health destination. The importance of these developments is evident, as they significantly enhance Saudi Arabia's international standing and its attractiveness to global investors in the healthcare and food sectors. Furthermore, these advancements positively impact the national economy by creating new investment opportunities, generating high-quality jobs for citizens, and generally improving public health quality. Consequently, Saudi Arabia has become a global model in healthcare regulation and food and drug safety. In conclusion, dear reader, the continuous and significant achievements of the SFDA underscore the ambitious vision adopted by the Kingdom to establish an advanced healthcare system based on global best practices, fundamentally aimed at enhancing the quality of life and ensuring public health and safety. These ongoing efforts solidify Saudi Arabia's position as a leader in healthcare at both regional and global levels.
Arab News
30-07-2025
- Arab News
Book Review: ‘The Hidden Vegetables Cookbook'
'I hate vegetables,' Heidi Herman writes in the opening to 'The Hidden Vegetables Cookbook: 90 Tasty Recipes for Veggie-Averse Adults.' For the latest updates, follow us on Instagram @ That bold admission hooked me from the first page and set the tone for Herman's book which will be released in September. Arab News received an advance copy of the publication for review. The cookbook offers nearly 100 clever recipes crafted and curated specifically for adults who want the nutritional benefits of vegetables, but perhaps without the taste or texture. Herman is not writing this book for exhausted parents sneaking in healthier ingredients for their finicky toddlers. These recipes are meant for grown-ups who want to mindfully devour nutritious and delicious dishes with complex flavors and creative combinations. Think banana muffins with riced cauliflower and ginger, Salisbury steak with spinach-laced brown gravy, enchiladas with stealthy carrots and onions, and a delectable chocolate cake made with undetectable zucchini. The goal is not to push green smoothies onto reluctant palates. Instead, Herman leans into comfort food — soups, bakes, pastas, and even desserts — where vegetables are quietly worked in. Growing up, Herman rarely thought about food or nutrition. Her breakfasts were usually rushed — grabbing whatever was readily available, lunch was usually from the school cafeteria, and dinner often from a boxed meal like Hamburger Helper. Her Icelandic mother called vegetables 'rabbit food' and they rarely served them at home, relying instead on seafood and dairy. In addition, 'Greens' were such a foreign concept that when her mother's doctor once told her to add more to her diet, she jokingly bought a bag of M&M's chocolate bits and picked out all the green ones to fulfill that serving. That vegetable avoidance was passed down to Herman. Also contributing to the book is Rhonda Thornton, a US National Board Certified Health and Wellness Coach. Thornton, who works with adults struggling to eat healthier, believes the secret lies in incorporating vegetables gradually and without pressure, like when stirred into sauces, baked into muffins or folded into familiar dishes. This book is for anyone who grew up coating broccoli in a blanket of cheese or avoiding the vegetable section altogether. It is also for anyone who wants to try to make smarter choices in the kitchen for the sake of their health, and to maybe devise some fun culinary experiments in the meantime.
Arab News
30-07-2025
- Arab News
Pakistan, WHO sign agreement to provide free cancer medication for children
ISLAMABAD: Pakistan has signed an agreement with the World Health Organization (WHO) to provide free cancer medication to thousands of children annually in the South Asian country, Pakistani state media reported on Tuesday. The agreement marks Pakistan's inclusion in the Global Platform for Access to Childhood Cancer Medicines (GCCM), a WHO-led initiative to expand access to life-saving cancer treatments for children in low- and middle-income countries. Pakistan Health Minister Mustafa Kamal announced that under this agreement, Pakistan will receive essential cancer medicines every year, benefitting approximately 8,000 children who are diagnosed with cancer annually in the country. 'The goal is simple but profound to save lives,' Kamal said. 'Currently, the survival rate for children with cancer in our region stands at just 30 percent. Through this agreement, we aim to increase that to 60 percent by ensuring timely access to quality treatment.' Around 8,000 new pediatric cases are reported each year but less than half receive timely diagnosis or treatment due to limited access to pediatric oncology centers, according to the Aga Khan University Hospital (AKUH). The overall mortality rate for those diagnosed remains alarmingly high and survival rates hover around 10–30 percent, compared to over 80 percent in high-income countries. Kamal shared the WHO will provide technical and operational support for the initiative, while United Nations Children's Fund (UNICEF) will take on the responsibility of procuring and supplying the medicines to Pakistan, appreciating both organizations and all partners for their support and commitment. 'Today is a big day for Pakistan. We are not just recipients; we are partners in global efforts to ensure that no child suffers or dies from a treatable disease,' he said. 'I thank WHO, UNICEF, the GCCM, and all our partner organizations. Our dream is a healthier society, and that begins with the health of our mothers and children.' On the occasion, WHO representative Dr. Dapeng Luo said no child affected by cancer should die because of lack of access to treatment, including quality-assured medicines. 'WHO will work side by side with the Ministry of Health and partners to save lives and leave no child behind, no matter where they live or who they are,' Luo said.
